Xarelto, an anticoagulant that was approved by the US Food and Drug Administration (FDA) in 2011, has been linked to an increased risk of uncontrollable bleeding (hemorrhaging).
What is Xarelto?
Xarelto (known generically as Rivaroxaban) is a new-generation anticoagulant, in a class of drugs known as direct thrombin inhibitors. It is a blood thinner used to reduce the risk of blood clots and strokes.
What You Should Know
Xarelto has reportedly been linked to an increased risk of uncontrollable bleeding (hemorrhaging). A risk of hemorrhaging exists in many blood thinners; however, warfarin has an antidote that can reduce the risk of uncontrollable hemorrhaging. Some newer blood thinners, including Xarelto, do not have such an antidote. This means that injuries—including minor cuts or internal bleeding—can result in uncontrolled bleeding, which can be fatal.
Injuries Resulting from Use of Xarelto
- Retinal hemorrhages
- Epidural hematoma
- Intracranial hemorrhages
- Pulmonary embolism
- Hemoglobin decrease
- Gastrointestinal hemorrhages
- Deep vein thrombosis
- Adrenal bleeding
Xarelto Lawsuit Evaluation: If you or a loved one suffered a bleeding episode after using Xarelto, you should contact The Falkowitz Law Firm immediately. You may be entitled to compensation by filing a Xarelto lawsuit and we can help.